-+ 0.00%
-+ 0.00%
-+ 0.00%

CAPRICOR THERAPEUTICS SHARES FALL 60% PREMARKET AFTER FDA STAFF REVIEW SAYS DATA FOR CO'S DUCHENNE CELL THERAPY DOES NOT PROVIDE SUBSTANTIAL EVIDENCE OF EFFECTIVENESS

路透·07/27/2026 12:18:49

登录查看新闻详情